Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 27% ± 10% | |
fibroblast | 9 studies | 24% ± 8% | |
epithelial cell | 7 studies | 32% ± 15% | |
adipocyte | 7 studies | 23% ± 6% | |
GABAergic neuron | 7 studies | 35% ± 20% | |
interneuron | 6 studies | 33% ± 21% | |
macrophage | 6 studies | 26% ± 6% | |
microglial cell | 6 studies | 24% ± 6% | |
astrocyte | 6 studies | 30% ± 11% | |
oligodendrocyte | 6 studies | 27% ± 5% | |
endothelial cell of lymphatic vessel | 5 studies | 29% ± 4% | |
glutamatergic neuron | 5 studies | 48% ± 21% | |
pericyte | 5 studies | 21% ± 6% | |
neuron | 4 studies | 30% ± 9% | |
plasma cell | 4 studies | 24% ± 7% | |
oligodendrocyte precursor cell | 4 studies | 32% ± 8% | |
goblet cell | 4 studies | 30% ± 22% | |
ciliated cell | 3 studies | 20% ± 2% | |
connective tissue cell | 3 studies | 24% ± 3% | |
lymphocyte | 3 studies | 21% ± 6% | |
basal cell | 3 studies | 36% ± 14% | |
smooth muscle cell | 3 studies | 20% ± 1% | |
mast cell | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2143.62 | 459 / 459 | 100% | 47.04 | 1118 / 1118 |
esophagus | 100% | 1507.01 | 1445 / 1445 | 100% | 33.46 | 183 / 183 |
liver | 100% | 1066.96 | 226 / 226 | 100% | 24.69 | 406 / 406 |
lung | 100% | 1916.88 | 578 / 578 | 100% | 42.21 | 1155 / 1155 |
ovary | 100% | 1826.60 | 180 / 180 | 100% | 37.88 | 430 / 430 |
pancreas | 100% | 1274.90 | 328 / 328 | 100% | 34.60 | 178 / 178 |
prostate | 100% | 1994.57 | 245 / 245 | 100% | 40.07 | 502 / 502 |
stomach | 100% | 1415.27 | 359 / 359 | 100% | 36.44 | 286 / 286 |
uterus | 100% | 2162.08 | 170 / 170 | 100% | 42.86 | 459 / 459 |
thymus | 100% | 1832.34 | 653 / 653 | 100% | 37.09 | 604 / 605 |
intestine | 100% | 1868.47 | 966 / 966 | 100% | 39.71 | 526 / 527 |
bladder | 100% | 1812.71 | 21 / 21 | 100% | 39.48 | 503 / 504 |
kidney | 100% | 1631.96 | 89 / 89 | 100% | 33.72 | 897 / 901 |
brain | 99% | 863.96 | 2606 / 2642 | 100% | 30.10 | 705 / 705 |
adrenal gland | 100% | 3550.12 | 258 / 258 | 98% | 31.94 | 226 / 230 |
skin | 100% | 2060.16 | 1809 / 1809 | 98% | 33.45 | 463 / 472 |
adipose | 100% | 2210.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.06 | 29 / 29 |
spleen | 100% | 1866.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 37.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.76 | 1 / 1 |
blood vessel | 100% | 1848.85 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1183.28 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1141.28 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 20.22 | 75 / 80 |
peripheral blood | 75% | 768.95 | 695 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006420 | Biological process | arginyl-tRNA aminoacylation |
GO_0006418 | Biological process | tRNA aminoacylation for protein translation |
GO_0032543 | Biological process | mitochondrial translation |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0004814 | Molecular function | arginine-tRNA ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | RARS2 |
Protein name | Probable arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS) arginine--tRNA ligase (EC 6.1.1.19) Arginyl-tRNA synthetase 2, mitochondrial arginine--tRNA ligase (EC 6.1.1.19) (Arginyl-tRNA synthetase) Arginyl-tRNA synthetase |
Synonyms | hCG_2031107 RARSL |
Description | FUNCTION: Catalyzes the attachment of arginine to tRNA(Arg) in a two-step reaction: arginine is first activated by ATP to form Arg-AMP and then transferred to the acceptor end of tRNA(Arg). . |
Accessions | ENST00000689174.1 ENST00000689206.1 ENST00000689952.1 A0A8I5KXM9 ENST00000685069.1 ENST00000684790.1 ENST00000692684.1 H0UI22 ENST00000687729.1 ENST00000686284.1 A0A8I5KWC6 A0A8I5KU19 ENST00000687586.1 ENST00000692394.1 ENST00000686988.1 A0A8I5KPR3 ENST00000690205.1 A0A8I5KX97 ENST00000688106.1 ENST00000685376.1 A0A8I5KPX4 ENST00000687579.1 A0A8I5QJX6 A0A8I5KVZ5 ENST00000691815.1 A0A8I5KQK8 A0A8I5KS21 ENST00000692843.1 ENST00000685881.1 ENST00000686154.1 A0A8I5KYL9 A0A8I5KP51 ENST00000686407.1 A0A8I5KWE8 ENST00000451155.2 A0A8I5KQS8 ENST00000691725.1 ENST00000685336.1 ENST00000686857.1 ENST00000693327.1 A0A8I5KQP4 ENST00000686142.1 ENST00000693605.1 ENST00000685701.1 Q5T160 A0A8I5KR42 ENST00000691238.1 ENST00000693431.1 ENST00000688532.1 ENST00000690622.1 ENST00000687909.1 A0A8I5KPZ0 A0A8I5KVK0 H0Y450 A0A8I5KRE6 ENST00000690705.1 A0A8I5KR81 A0A8I5KS32 ENST00000369536.10 ENST00000692270.1 A0A8I5QJN6 ENST00000685408.1 ENST00000690884.1 A0A8I5KPZ4 A0A8I5KQV7 ENST00000687437.1 |